Company Presentation

NovaGo Therapeutics

Category:Emerging Biotech Company
Time:13:00 – 13:15
Speaker:Stefan Moese, CEO

Company profile

NovaGo Therapeutics is a Swiss biotech company focused on human antibody therapeutics targeting nerve growth and regeneration to enhance functional recovery following spinal cord injury, stroke and diabetic retinopathy. NovaGo’s therapeutic antibody candidates have shown to enhance nerve repair and functional recovery in preclinical models. Phase 1b clinical trials for the treatment of spinal cord injury are planned to start in 2024.

Follow us